What alternative treatments are available for adenomyosis in a patient who cannot use an intrauterine device?

Alternative Treatment Options for Adenomyosis When IUD is Not Favored

Combined oral contraceptives should be your first-line medical alternative when IUD is not an option, followed by oral GnRH antagonists if contraceptives fail or are contraindicated. 1

Medical Management Hierarchy

First-Line: Hormonal Contraceptives

• Combined oral contraceptives have demonstrated significant reduction in painful and heavy menstrual bleeding in randomized controlled trials for adenomyosis 1
• While progestin IUDs are clinically superior due to local action and lower systemic hormone levels, a recent RCT showed combined oral contraceptives still provide significant improvement in pain and bleeding when IUD is not feasible 1
• Dienogest (where marketed) appears superior to combined oral contraceptives and should be considered if available 1

Second-Line: GnRH Antagonists

• Oral GnRH antagonist combinations are highly effective for heavy menstrual bleeding in adenomyosis
• Pooled analysis of 2 RCTs confirms effectiveness is not decreased by presence of adenomyosis 1
• These should be considered when first-line hormonal options fail or are not tolerated
• Important caveat: These therapies will not treat bulk symptoms (pressure, fullness, bladder/bowel symptoms) 1

Procedural/Interventional Options

Uterine Artery Embolization (UAE)

UAE is the most evidence-supported uterus-sparing procedural option for adenomyosis, particularly when medical management fails 2, 1, 2, 1, 2

Efficacy data:

• Short-term (<12 months): 94% symptom improvement
• Long-term (>12 months): 85% symptom improvement
• 7% hysterectomy rate for persistent symptoms 1
• Long-term follow-up (up to 7 years) shows sustained improvement in quality of life and symptom scores 1
• Recent studies report 73-88% symptomatic control at 24-65 months follow-up 2

Key considerations:

• Works for both bleeding and bulk symptoms
• 18% may require eventual hysterectomy for persistent symptoms 1
• Fertility data after UAE for adenomyosis is limited; counsel patients accordingly 1
• The ongoing QUESTA trial is comparing UAE versus hysterectomy outcomes 1

High-Intensity Focused Ultrasound (HIFU/MRgFUS)

• MR-guided focused ultrasound is emerging as a non-invasive option 3, 4
• Can effectively reduce lesion size and alleviate symptoms 3
• Real-time temperature monitoring and immediate postoperative assessment with MRI guidance 3
• Major limitation: Currently no relevant literature specifically for adenomyosis treatment in the ACR guidelines 1
• More data needed, particularly for diffuse adenomyosis 4, 5

Radiofrequency Ablation (RFA)

• Proven effective in reducing abnormal uterine bleeding and dysmenorrhea 4
• Associated with decreased uterine volume 4
• Critical limitation: Access in the USA is limited and primarily off-label due to lack of FDA approval 4

Endometrial Ablation

• Can be considered for heavy menstrual bleeding when medical therapy fails 1, 6
• Important pitfall: Treatment failure of endometrial ablation has been associated with presence of adenomyosis 1
• Only indicated in patients who do not desire future pregnancy 1
• Does not address bulk symptoms

Surgical Options

Adenomyomectomy/Cytoreductive Surgery

• Effective in ameliorating abnormal uterine bleeding and pelvic pain 7, 8
• Reduces uterine volume 7
• Should only be performed by experienced surgeons in dedicated centers, especially with concomitant endometriosis 7
• May be considered for localized adenomyosis in fertility-preserving cases 8
• Carries post-operative risks and potential obstetric complications 7

Hysterectomy (Definitive)

• Provides definitive resolution of all adenomyosis symptoms 1
• Should be avoided if less invasive procedures are available due to:
  • Increased severe complications versus UAE 1
  • Longer hospitalization and recovery 1
  • Long-term risks: cardiovascular disease, osteoporosis, bone fracture, dementia 1
  • Increased mortality risk, especially when performed at young age 1
• If performed, use least invasive route: vaginal > laparoscopic > abdominal 1

Clinical Algorithm

For bleeding-dominant symptoms:

1. Combined oral contraceptives or dienogest (if available)
2. Oral GnRH antagonists if first-line fails
3. UAE if medical management fails and uterus preservation desired
4. Endometrial ablation (if no fertility desired, though higher failure risk)
5. Hysterectomy only if all else fails

For bulk-dominant symptoms:

1. UAE (medical therapy won't help bulk symptoms)
2. Consider HIFU/RFA if available
3. Adenomyomectomy by experienced surgeon if localized disease
4. Hysterectomy as last resort

For fertility preservation:

1. Time-limited medical therapy (combined OCs, dienogest, short-term GnRH antagonists)
2. Adenomyomectomy for localized disease only
3. UAE with extensive counseling about limited fertility data

Common pitfall: Do not use endometrial ablation as first-line—it has higher failure rates in adenomyosis patients and should only follow failed medical therapy 1.